24/11/2009

GlaxoSmithKline Halts H1N1 Vaccinations In Canada. -- (Manufacturing.net)

 

....British drug maker GlaxoSmithKline Plc. is suspending the use of 170,000 doses of its new H1N1 influenza vaccine in Canada given a higher-than-usual rate of reported side effects, Canadian media reported Monday.......anaphylaxis, an allergic reaction causing breathing difficulties and reduced blood pressure....

GlaxoSmithKline Halts H1N1 Vaccinations In Canada

13:39 Écrit par Dr MSFV | Lien permanent | Commentaires (0) |  Facebook |

Les commentaires sont fermés.